Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CBP-1019
i
Other names:
CBP-1019, CBP1019, CBP 1019
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Coherent Biopharma
Drug class:
DNA topoisomerase inhibitor, Folate receptor 1 inhibitor, TRPV6 inhibitor
Related drugs:
‹
SNB-101 (2)
L-ANN (2)
rubitecan (1)
pirarubicin (1)
E7040 (0)
EGFREDVDox (0)
SSS22 (0)
CBP-1008 (3)
CT900 (2)
AFVT-2101 (0)
CBP-1018 (0)
ITIL-306 (0)
MOv18 IgE (0)
TPIV200 (0)
vintafolide (0)
MORAB-003 (0)
EC1456 (0)
SOR C13 (0)
SNB-101 (2)
L-ANN (2)
rubitecan (1)
pirarubicin (1)
E7040 (0)
EGFREDVDox (0)
SSS22 (0)
CBP-1008 (3)
CT900 (2)
AFVT-2101 (0)
CBP-1018 (0)
ITIL-306 (0)
MOv18 IgE (0)
TPIV200 (0)
vintafolide (0)
MORAB-003 (0)
EC1456 (0)
SOR C13 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login